Table S1.
Characteristics of patients with RA at screening visit
| Characteristics | RA patients (n=19) |
|---|---|
| Female:male | 16:3 |
| Age (years)* | 56.42 (24/75) |
| Duration of RA (years)* | 10.3 (0.2/37.6) |
| RF* | 231 (1/1,600) |
| ACPA* | 241.7 (0/1,000) |
| DAS28* | 4.81 (2.72/6.86) |
| ESR (mm/h)* | 22.68 (2/60) |
| CRP (mg/dL)* | 0.98 (0.03/6.56) |
| Glucocorticoid treatment | 13 (68%) |
| DMARDs | 19 (100%) |
| NSAIDs | 11 (58%) |
Note:
*
Data are given as mean (minimum/maximum) or number (%).
Abbreviations: RF, rheumatoid factor; ACPA, anti-citrullinated peptide antibodies; DAS28, disease activity score of 28 joints; ESR, erythrocyte sedimentation rate; CRP, c-reactive protein; DMARDs, disease modifying antirheumatic drugs; NSAIDs, non-steroidal anti-inflammatory drugs; RA, rheumatoid arthritis.